Melatonin directly binds and inhibits death‐associated protein kinase 1 function in Alzheimer’s disease
- 1 May 2020
- journal article
- research article
- Published by Wiley in Journal of Pineal Research
- Vol. 69 (2), e12665
- https://doi.org/10.1111/jpi.12665
Abstract
Death‐associated protein kinase 1 (DAPK1) is upregulated in the brains of human Alzheimer’s disease (AD) patients compared with normal subjects, and aberrant DAPK1 regulation is implicated in the development of AD. However, little is known about whether and how DAPK1 function is regulated in AD. Here, we identified melatonin as a critical regulator of DAPK1 levels and function. Melatonin significantly decreases DAPK1 expression in a post‐transcriptional manner in neuronal cell lines and mouse primary cortical neurons. Moreover, melatonin directly binds to DAPK1 and promotes its ubiquitination, resulting in increased DAPK1 protein degradation through a proteasome‐dependent pathway. Furthermore, in tau‐overexpressing mouse brain slices, melatonin treatment and the inhibition of DAPK1 kinase activity synergistically decrease tau phosphorylation at multiple sites related to AD. In addition, melatonin and DAPK1 inhibitor dramatically accelerate neurite outgrowth and increase the assembly of microtubules. Mechanistically, melatonin‐mediated DAPK1 degradation increases the activity of Pin1, a prolyl isomerase known to play a protective role against tau hyperphosphorylation and tau‐related pathologies. Finally, elevated DAPK1 expression shows a strong correlation with the decrease in melatonin levels in human AD brains. Combined, these results suggest that DAPK1 regulation by melatonin is a novel mechanism that control tau phosphorylation and function and offers new therapeutic options for treating human AD.Keywords
This publication has 81 references indexed in Scilit:
- Melatonin in Alzheimer’s DiseaseInternational Journal of Molecular Sciences, 2013
- Death-Associated Protein Kinase 1 Phosphorylates Pin1 and Inhibits Its Prolyl Isomerase Activity and Cellular FunctionMolecular Cell, 2011
- DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicityCell Death & Differentiation, 2011
- The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responsesThe EMBO Journal, 2010
- DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in StrokeCell, 2010
- Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau PathologyJournal of Neuroscience, 2009
- Pin1 has opposite effects on wild-type and P301L tau stability and tauopathyJCI Insight, 2008
- Regulation of Death-associated Protein KinaseOnline Journal of Public Health Informatics, 2007
- Control of Death-associated Protein Kinase (DAPK) Activity by Phosphorylation and Proteasomal DegradationOnline Journal of Public Health Informatics, 2006
- 100 Years and Counting: Prospects for Defeating Alzheimer's DiseaseScience, 2006